Clinical Trial Update: Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial at Ohio State Comprehensive Cancer Center is testing a neoadjuvant complete-response–driven, customized treatment approach for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Breast Cancer, HER2-positive Breast Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING